Progesterone Balance

Progesterone Balance: A Comprehensive Reference

1. Definition and Overview

Progesterone is an endogenous steroid hormone that is commonly produced by the adrenal cortex as well as the gonads, which consist of the ovaries and the testes. The conversion of progesterone generation from the corpus luteum to the placenta generally occurs after week ten of pregnancy. The molecule progesterone is a derivative of cholesterol and has numerous functions in the human body, especially within the reproductive system.

In the context of natural health and nutritional medicine, the term progesterone balance refers to the maintenance of physiologically appropriate progesterone levels relative to other hormones — particularly estrogen — across the various phases of the menstrual cycle, pregnancy, perimenopause, and menopause. Progesterone is a steroid hormone traditionally linked with female fertility and pregnancy, and in current reproductive medicine, progesterone and its analogues play crucial roles. Disruptions to this balance — whether as absolute deficiency, relative insufficiency compared to estrogen, or excess — give rise to a distinct cluster of physiological and psychological manifestations.

The effects of progesterone are mediated by the progesterone receptor (PR), a member of the nuclear receptor superfamily of transcription factors that regulate gene expression upon hormonal stimulation. There are two major progesterone receptors, progesterone receptor A (PR-A) and progesterone receptor B (PR-B), which are expressed equally under physiological conditions; both receptors are coded by a single gene on chromosome 11.

2. Body Systems Involved

2.1 The Reproductive System

Progesterone helps regulate the menstrual cycle, but its main job is to get the uterus ready for pregnancy. After ovulation each month, progesterone helps thicken the lining of the uterus to prepare for a fertilized egg. If there is no fertilized egg, progesterone levels drop and menstruation begins. If a fertilized egg implants in the uterine wall, progesterone helps maintain the uterine lining throughout pregnancy.

Progesterone and novel progestins have many important functions, including contraception, luteal phase support, treatment of dysfunctional uterine bleeding, and endometriosis. Progesterone and estrogen are required for normal breast duct formation via estrogen receptors (ERs) and progesterone receptors (PR) stimulation. Cell proliferation rate in the breast's lobular structures is directly proportionate to the level of PRs and ERs in the tissue.

2.2 The Neuroendocrine System

In response to the release of GnRH, the anterior pituitary will release FSH and LH, which will subsequently act on the gonads; in the female ovary, this release causes the production of progesterone. Excess amounts of progesterone will cause negative feedback inhibition on each prior organ, resulting in the cessation of the release of hormones. This process allows for regulated control of hormone levels. Abnormalities of this axis result in dysregulation of hormone levels affecting numerous organ systems and downstream hormones within the body.

Although progesterone is primarily associated with the reproductive system, it also plays a functional role in the neuroendocrine axis. Progesterone freely passes the blood-brain barrier, is metabolized in the brain to allopregnanolone and pregnanolone, which, by stimulating the gamma-aminobutyric acid (GABA) inhibitory system, mediates some of the neuropsychiatric symptoms of PMS.

2.3 The Central Nervous System

Progesterone also plays an important role in the nervous system. Its neurogenic effect is essential for normal brain development in fetuses, while the neuroprotective effect of progesterone improves patient survival after traumatic brain injury. Progesterone and allopregnanolone also have the ability to modulate further neurotransmitter systems, such as the serotonergic, cholinergic, and dopaminergic systems. The serotonergic system serves various roles, mostly in mood balancing. On the other hand, progesterone interacts with the central serotonergic system by reducing the bioavailability of serotonin through the activation of monoamine oxidase.

2.4 The Cardiovascular and Fluid Regulation Systems

Progesterone also plays an important role in mammary gland development and affects the function of the central nervous system and cardiovascular system. One mechanism by which estrogens or progesterone may impact physiological systems is through regulation of body fluids and sodium content. Receptors for estrogens and progesterone are found in nonreproductive tissue involved in fluid regulation, such as the hypothalamus.

2.5 The Immune System

Progesterone has an important role in immune response and also in the prevention and treatment of various cancers. Progesterone is considered a neurosteroid, and its therapeutic potential for brain damage could represent a potential treatment option. Moreover, it has the ability to reduce oxidative stress through enhancing the free radical scavenging system, anti-inflammatory potential, and beneficial effects on the cardiovascular system, bone balance, and metabolic processes.

3. How Progesterone Imbalance Presents

3.1 Signs and Symptoms of Deficiency

The most noticeable manifestation of low progesterone levels is irregular periods and short cycles, but sometimes symptoms like premenstrual spotting may appear. Other symptoms may include mood changes, sleep disturbances, anxiety, and depression.

Having low progesterone can lead to having too much estrogen, which can cause symptoms like weight gain. Progesterone is known for its calming, anti-anxiety effect as it supports the brain's GABA receptors, which helps the person feel relaxed. When progesterone levels drop, this can cause anxiety, stress, and mood swings.

Sleep disturbances are one of the classic symptoms of low progesterone. The hormone supports the brain's ability to relax and unwind. When levels fall, sleep can become lighter, more disrupted, and less restorative.

3.2 The Concept of Relative Estrogen Dominance

A clinically important dimension of progesterone balance is not merely absolute deficiency but relative imbalance. Estrogen and progesterone work in tandem, so the slightest imbalance in one inevitably leads to an imbalance in the other. Progesterone deficiency and estrogen dominance result in similar symptoms and hormonal imbalance. Too much estrogen relative to progesterone can worsen PMS, cause bloating, breast tenderness and swelling, decrease sex drive, cause fibroids, and even increase breast cancer risk over time.

3.3 Luteal Phase Deficiency

Luteal phase defect is a common endocrine disorder associated with infertility and spontaneous miscarriage. Abnormalities of the luteal phase are found in 3% to 10% of the female population with primary or secondary infertility and in 35% of those with repeated or habitual abortion. Infertility and pregnancy loss associated with this disorder are thought to be caused by inadequate maturation and development of the endometrium, attributable to insufficient progesterone production by the corpus luteum.

3.4 Perimenopause and Menopause

Many women report feeling more anxious or irritable, especially during the second half of their cycle or throughout perimenopause or menopause, when progesterone production starts to decline. During the last decades, particular attention has been paid to explore the association of hormonal dysregulation with depression, cognitive functioning, anxiety disorders, as well as with fluid retention. The pathophysiology of PMS is complex, imprecise, and not fully understood, although there is some evidence to support the possible role of progesterone.

4. Contributing and Associated Factors

4.1 Stress and the Hypothalamic–Pituitary–Adrenal Axis

High stress: cortisol is the stress hormone, and too much of it can interfere with the body's ability to make progesterone. Stress activates the autonomic nervous system (ANS) and the hypothalamic-pituitary-adrenal axis (HPAA). Based on a systematic literature review of the impact of endogenous and exogenous exposure with natural progesterone on the stress response in healthy premenopausal and postmenopausal women, the HPAA activity was not relevantly affected by endogenous progesterone exposure across the menstrual cycle, but might be reduced by exogenous micronized progesterone application.

4.2 Hypothyroidism

Hypothyroidism — a slow or underactive thyroid — makes it harder for the body to make progesterone. The thyroid glands produce T3 and T4, which help regulate the endocrine system. Hypothyroidism can affect progesterone levels as it decreases the functions of the ovaries or increases the prolactin level.

4.3 Hyperprolactinemia

Hyperprolactinemia — where the body makes too much prolactin, the hormone responsible for lactation — disrupts other sex hormones like progesterone, leading to irregular cycles or loss of the menstrual period.

4.4 Low Cholesterol

Low levels of cholesterol can cause low progesterone, which is mechanistically consistent with the finding that the molecule progesterone is a derivative of cholesterol.

4.5 Under-Fueling, Exercise, and Energy Availability

Over-exercising or extreme dieting can increase cortisol levels and put stress on the body, and it also deprives the body of key nutrients needed to sustain healthy hormone levels. Prior research has shown positive associations between luteal phase deficiency (LPD) and low energy availability, either through high dietary restraint alone or in conjunction with high energy expenditure via exercise.

4.6 Body Composition and Obesity

Obese or overweight women can experience suppressed progesterone production. Obesity along with low progesterone is connected with endometrial cancer. Conversely, very low body fat impairs hormonal function as well: a female body needs at least 12% body fat to perform all hormonal functions properly, and for women who exercise vigorously and have dropped their body fat ratio, have eating disorders, or other medical issues, menstruation and ovulation may stop.

4.7 Perimenopause

Perimenopause — the time just before menopause — is a primary physiological context in which hormone levels, including progesterone, decline.

5. Nutrients Studied in Relation to Progesterone Balance

The following section reviews micronutrients that have been discussed in the context of progesterone production or luteal phase support. Traditional use and scientific evidence are clearly distinguished throughout.

5.1 Vitamin C (Ascorbic Acid)

Traditional / Rational Use: Vitamin C has been used nutritionally to support ovarian function given its known high concentration in ovarian tissue, particularly the corpus luteum.

Scientific Evidence: Luteal phase defect is a common endocrine disorder associated with infertility and spontaneous miscarriage, with abnormalities of the luteal phase found in 3% to 10% of the female population with primary or secondary infertility. A key controlled study was conducted by Henmi et al. (2003), published in Fertility and Sterility. Henmi et al. studied 122 patients with infertility and luteal phase defects based on peak progesterone level below 10 ng/mL. Seventy-six patients in the study group received 750 mg of vitamin C per day. The vitamin C group had a significant increase (approximately 5–6 ng/mL) in progesterone level, and 25% of them became pregnant with a miscarriage rate of 15.8%, whereas 10.9% of the control group became pregnant with a miscarriage rate of 20%. Specifically, ascorbic acid supplementation improved the progesterone level in 40 of 76 (53%) treated patients, compared to 10 of 46 (22%) in the control group, and the difference was statistically significant. A study in women diagnosed with LPD indicated that vitamin C supplementation can increase serum progesterone concentrations to healthy control levels and improve the clinical pregnancy rate.

Evidence strength: This is a single non-randomized controlled study with a relatively modest sample. The findings are promising but require replication in larger, properly randomized trials before definitive conclusions can be drawn.

5.2 Vitamin B6 (Pyridoxine)

Traditional / Rational Use: Vitamin B6 (pyridoxine) is traditionally used to support or treat low progesterone levels, particularly in the context of premenstrual syndrome (PMS) and luteal phase defects. The rationale stems from early studies and anecdotal reports suggesting that vitamin B6 may help regulate hormonal balance, possibly by influencing neurotransmitter synthesis (such as serotonin and dopamine) and promoting the conversion of tryptophan to niacin, which may indirectly affect progesterone production.

Scientific Evidence: Some small clinical trials from the 1970s and 1980s reported improvements in PMS symptoms — some of which may be related to low progesterone — when women supplemented with vitamin B6. However, these studies often had methodological limitations, such as small sample sizes and lack of rigorous controls. Current scientific evidence directly linking vitamin B6 supplementation with increased progesterone levels is limited and inconsistent. Vitamin B6 is important for overall steroid hormone function. A meta-analysis suggested that 100 mg of B6 per day may help with PMS and premenstrual dysphoric disorder, which are associated with low progesterone. However, while B6 plays a role in overall hormone metabolism and may improve certain PMS symptoms, robust clinical trials confirming its specific effect on raising progesterone are lacking.

Evidence strength: Weak to preliminary for direct progesterone-raising effects; moderate for symptomatic PMS relief via indirect mechanisms.

5.3 Zinc

Traditional / Rational Use: Zinc has long been recognized as essential for reproductive health across multiple traditional systems.

Scientific Evidence: Zinc has an impact on a number of different areas of the body which are essential in the production of progesterone, including the ovaries and the pituitary gland. Zinc increases the production of Follicle Stimulating Hormone (FSH), which in turn causes ovulation and leads to the production of progesterone. This mechanism is indirect — zinc supports the upstream hormonal cascade (FSH → ovulation → corpus luteum → progesterone) rather than directly stimulating progesterone synthesis. Robust, large-scale human clinical trials specifically measuring luteal progesterone in response to zinc supplementation are currently limited in the peer-reviewed literature.

Evidence strength: Mechanistically plausible and supported by nutritional physiology, but direct clinical evidence in humans remains preliminary.

5.4 Magnesium

Traditional / Rational Use: Magnesium has widespread use in traditional natural medicine for menstrual and hormonal complaints.

Scientific Evidence: Animal and clinical studies suggest complementary effects of magnesium and high-dose pyridoxine (vitamin B6) on stress reduction. Magnesium's role in progesterone balance is largely indirect: it acts by modulating the HPA axis (the primary stress-response pathway), thereby potentially attenuating stress-related cortisol elevation, which in turn may relieve suppression of progesterone production. Vitamin D and magnesium are two of the most effective supplements for overall hormone balance, supporting estrogen, progesterone, and cortisol regulation. Direct evidence from randomized controlled trials demonstrating measurable increases in luteal-phase progesterone concentrations with magnesium supplementation in humans is limited.

Evidence strength: Indirect and preliminary for progesterone specifically; stronger for PMS and stress modulation.

5.5 Omega-3 Fatty Acids

Traditional / Rational Use: Omega-3 fatty acids from marine sources have long been used in traditional diets associated with reproductive health.

Scientific Evidence: Marine omega-3 polyunsaturated fatty acids (EPA, docosapentaenoic acid, and DHA) were associated with increases in luteal-phase progesterone concentrations. Specifically, intakes of these fatty acids in the third tertile compared with the first tertile were associated with significantly increased progesterone concentrations. Additionally, cycles in which women consumed docosapentaenoic acid in the second and third tertiles of intake had a significantly reduced risk of being anovulatory (RR for tertile 3 compared with tertile 1: 0.42; 95% CI: 0.18, 0.95). This is observational data from the BioCycle Study, which limits causal inference.

Evidence strength: Moderate observational evidence; consistent with biological plausibility. Causality not established from this data alone.

6. Herbs and Botanical Ingredients

6.1 Vitex agnus-castus (Chasteberry)

Traditional Use: Vitex agnus-castus (chaste tree; chasteberry) is a popular herbal treatment predominantly used for a range of female reproductive conditions in Anglo-American and European practice. Its use in Europe dates to classical antiquity, and it appears in European herbal traditions as a remedy for menstrual irregularity and luteal phase complaints.

Proposed Mechanism: The proposed mechanism is gentle modulation of dopaminergic activity, which influences prolactin balance. By lowering elevated prolactin, Vitex may indirectly support normal ovulation and subsequent progesterone production by the corpus luteum.

Scientific Evidence: A systematic review by Van Die et al. (2013), published in Planta Medica, examined 13 randomized controlled trials. For premenstrual syndrome, seven of eight trials found Vitex extracts to be superior to placebo (five of six studies), pyridoxine, and magnesium oxide. In premenstrual dysphoric disorder, one study reported Vitex to be equivalent to fluoxetine. In latent hyperprolactinemia, one trial reported it to be superior to placebo for reducing TRH-stimulated prolactin secretion, normalizing a shortened luteal phase, and increasing mid-luteal progesterone and 17β-estradiol levels. Adverse events with Vitex were mild and generally infrequent. The methodological quality of the included studies varied, but was generally moderate-to-high.

A separate meta-analysis of 17 RCTs by Csupor et al. found that thirteen of 14 studies with placebo, dietary supplements, or herbal preparations as controls reported positive effects of Vitex agnus castus on total PMS symptoms. Unfortunately, most of the trials are associated with a high risk of bias. The pooled effect of Vitex agnus castus in placebo-controlled trials was large (Hedges g, -1.21; 95% confidence interval, -1.53 to -0.88), but heterogeneity was extremely high (I², 91%). The funnel plot and Egger tests suggest the presence of publication bias.

Evidence strength: Moderate — consistent positive signals across multiple RCTs for PMS symptom reduction and possible luteal phase normalization; limited by high heterogeneity, small study sizes, and publication bias concerns. The most clinically validated use is for PMS and hyperprolactinemia-associated luteal dysfunction.

6.2 Ashwagandha (Withania somnifera)

Traditional Use: Ashwagandha, or Withania somnifera, is an Ayurvedic adaptogen known for lowering cortisol and aiding hormone balance. It has been used in Ayurvedic medicine for millennia for conditions attributed to stress and reproductive insufficiency.

Scientific Evidence: In the context of progesterone balance, ashwagandha's relevance is primarily through the stress–cortisol–progesterone axis. Research has demonstrated that ashwagandha significantly reduces the total Menopause Rating Scale (MRS) score and significantly increases serum estradiol and reduces follicle-stimulating hormone (FSH) and luteinizing hormone (LH) concentrations. Despite this, the mechanism of ashwagandha root extract's influence on the reproductive system is not fully understood; it might be related to its adaptogenic, anti-inflammatory, and antioxidant effects. Another possible mechanism could be ashwagandha's GABA mimetic action, stimulating gonadotropin-releasing hormone and thus improving hormonal balance.

Evidence strength: Moderate for stress and cortisol reduction; preliminary for direct reproductive hormonal effects, including on progesterone. Larger, longer RCTs are needed.

6.3 Maca Root (Lepidium meyenii)

Traditional Use: Maca root is a Peruvian root vegetable native to the Andes Mountains. It has traditionally been used to boost fertility, regulate reproductive health, and balance hormones, partly because it may help support the endocrine system.

Scientific Evidence: Some research suggests that maca root could also help relieve perimenopause symptoms. The mechanism of maca's hormonal effects is not fully understood; it is not a phytoestrogen but may act on the hypothalamic-pituitary axis. Evidence on direct hormone changes from maca is mixed. Its use specifically in the context of progesterone elevation remains insufficiently studied in rigorous RCTs.

Evidence strength: Preliminary. Existing evidence is limited and heterogeneous; direct effects on progesterone in particular are not well-established from high-quality clinical trials.

6.4 Red Clover (Trifolium pratense) and Phytoestrogens

Traditional Use: Red clover has been used in European and North American folk medicine for menopausal complaints and as a general "blood purifier."

Scientific Evidence: Red clover contains isoflavones, which are phytoestrogens — plant compounds that can bind weakly to estrogen receptors. A 2021 meta-analysis of randomized controlled trials found that supplementation with red clover isoflavone extract significantly reduced the daily frequency of hot flashes in peri- and postmenopausal women compared to placebo. However, the primary mechanism is estrogenic modulation rather than direct progesterone elevation. Phytoestrogens are plant compounds that weakly mimic estrogen in the body by binding to estrogen receptors. Their relevance to progesterone balance is indirect: by modulating estrogen receptor activity, they may normalize the estrogen-to-progesterone ratio in some contexts, though this is not well-established in clinical trials.

Evidence strength: Moderate for menopausal vasomotor symptoms via estrogenic pathways; weak to absent for direct progesterone augmentation.

6.5 Shatavari (Asparagus racemosus)

Traditional Use: Shatavari is traditionally used in Ayurveda to nurture female wellness and support reproductive vitality across different life stages.

Scientific Evidence: In 2017, a comprehensive literature review of both experimental and clinical studies demonstrated its versatile use in managing menstrual irregularities and polycystic ovary syndrome (PCOS). However, published high-quality RCTs specifically measuring luteal-phase progesterone as a primary outcome are limited. Most available evidence is preclinical or from observational studies of mixed quality.

Evidence strength: Preliminary; traditional use is well-documented but rigorous clinical evidence in humans is limited.

7. Dietary Factors

7.1 Dietary Fat and Macronutrient Composition

Since progesterone is synthesized from cholesterol, the type and quantity of dietary fat has attracted research attention. Marine omega-3 polyunsaturated fatty acids (EPA, DHA, and docosapentaenoic acid) were associated with increases in luteal-phase progesterone concentrations. Specifically, intakes of these fatty acids in the third tertile compared with the first tertile were associated with significantly increased progesterone concentrations.

The BioCycle Study (2005–2007) — a prospective observational study enrolling 259 women across the menstrual cycle — examined dietary factors and LPD. Higher Mediterranean Diet Score (MDS) was observed for LPD cycles compared with normal cycles after adjusting for age, percentage body fat, and total energy intake. Higher intakes of vegetable protein and fiber were also observed in LPD cycles after adjustment, as were higher servings of fruits and vegetables, and higher isoflavone and vitamin B6 intake in LPD cycles. This counterintuitive finding (a "healthier" diet correlating with LPD) deserves careful interpretation; previous studies have also shown that diets high in fiber and/or low in fat are associated with decreased progesterone concentrations. These associations suggest that extreme restriction of dietary fat can negatively impact luteal progesterone.

7.2 Cruciferous Vegetables and Estrogen Metabolism

Although cruciferous vegetables do not directly raise progesterone, they are widely discussed in the context of progesterone balance through their role in modulating estrogen metabolism — and thereby the estrogen-to-progesterone ratio. Cruciferous vegetables are a family of green vegetables that include watercress, radish, cabbage, broccoli, cauliflower, Brussels sprouts, and kale. They are a rich source of compounds known as glucosinolates; when digested, glucosinolates are metabolized to indole-3-carbinol (I3C) and diindolylmethane (DIM), which provide a regulatory effect on estrogen by selectively binding to receptors in the body.

The U.S. Department of Veterans Affairs Whole Health Library notes that cruciferous vegetables and broccoli derivatives, including indole-3-carbinol (I3C) and diindolylmethane (DIM), have been shown to shift estrogen metabolism toward the 2-hydroxyestrone pathway. Additionally, a high-fiber diet decreases the amount of estrogen absorbed and increases the amount of estrogen excreted.

7.3 Overall Dietary Pattern

When adopting a Mediterranean-style diet, which is predominantly plant-based, fiber-rich, and nutrient-dense, with plenty of healthy fats and lean protein, it can help support hormone-producing and -eliminating systems, bringing hormones back into balance. One study on postmenopausal women following a Mediterranean eating pattern for 6 months demonstrated a more than 40% decrease of total estrogen levels, as well as the estradiol and estrone metabolites.

8. Lifestyle Factors

8.1 Stress Management

Chronic stress increases cortisol, which can throw off estrogen–progesterone balance. The HPA axis activation under chronic stress is a primary mechanism through which lifestyle-induced progesterone imbalance occurs, as elevated cortisol competes with, and can redirect, the steroidogenic pathway away from progesterone synthesis.

8.2 Physical Activity

Physical activity helps the body process and eliminate estrogen. It also supports healthy weight, reduces stress, and improves gut function. However, excessive exercise — particularly in association with energy restriction — represents a significant risk factor for suppression of ovulation and thus progesterone production. Prior research has shown positive associations between luteal phase deficiency and low energy availability, either through high dietary restraint alone or in conjunction with high energy expenditure via exercise.

8.3 Sleep

Poor sleep affects hormone balance, including estrogen. Most adults need seven to nine hours per night. Creating a consistent sleep routine supports overall hormonal health. Progesterone itself has well-recognized sleep-promoting properties via its conversion to neurosteroids that act on GABA receptors, creating a bidirectional relationship between progesterone levels and sleep quality.

8.4 Body Weight Maintenance

Both obesity and underweight states are documented risk factors for progesterone imbalance. Being overweight or obese can also lead to lower progesterone levels, as fat cells produce estrogen. Conversely, the female body requires a minimum threshold of body fat for full endocrine function, and extremes in either direction disrupt ovulation and luteal steroidogenesis.

9. Summary of Evidence Strength by Intervention

• Vitex agnus-castus: Moderate — Multiple RCTs and meta-analyses support PMS symptom relief and luteal phase normalization, particularly in the context of latent hyperprolactinemia; high heterogeneity and publication bias are limitations.
• Vitamin C: Preliminary — One controlled study (Henmi et al., 2003) showed significant increases in progesterone in women with LPD; requires replication in larger RCTs.
• Omega-3 fatty acids: Moderate observational — Consistent associations between marine omega-3 intake and luteal-phase progesterone in the BioCycle Study; causality not established.
• Ashwagandha: Moderate for cortisol/stress; preliminary for direct progesterone effects.
• Vitamin B6: Weak to preliminary for direct progesterone elevation; moderate for PMS symptom relief through indirect pathways.
• Magnesium: Indirect and preliminary for progesterone; moderate for stress modulation.
• Zinc: Mechanistically plausible (via FSH pathway); clinical trial evidence in humans specifically for luteal progesterone is limited.
• Maca root: Preliminary; direct progesterone effects not well-established in high-quality RCTs.
• Red clover / phytoestrogens: Moderate for menopausal vasomotor symptoms; weak for direct progesterone augmentation.
• Cruciferous vegetables / DIM / I3C: Moderate for modifying estrogen metabolism via hepatic pathways; indirect relevance to progesterone balance.

References

• Cable JK, Grider MH. Physiology, Progesterone. StatPearls [Internet]. NIH/NCBI Bookshelf, 2021.
• Tal R, Taylor HS. Key to Life: Physiological Role and Clinical Implications of Progesterone. International Journal of Molecular Sciences. 2021;22(20):11039. PMC.
• Kohl Schwartz AS, et al. Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine. PMC. 2022.
• Berta DG, et al. New insights into the functions of progesterone receptor (PR) isoforms and progesterone signaling. PMC. 2021.
• Stachenfeld NS. Sex Hormone Effects on Body Fluid Regulation. PMC. 2008.
• Cleveland Clinic. Low Progesterone: Causes, Symptoms, Tests & Treatment. 2023.
• Roche DJ, et al. Impact of endogenous and exogenous progesterone exposure on stress biomarkers: a systematic review. PubMed. 2019.
• Van Die MD, et al. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. DARE, NCBI Bookshelf (Planta Medica 2013;79(7):562-575).
• Csupor D, et al. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. PubMed. 2017.
• Cerqueira RO, et al. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2017.
• Henmi H, et al. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertility and Sterility. 2003;80(2):459-461.
• Henmi H, et al. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. PubMed. 2003.
• Wise LA, et al. Dietary fat intake and reproductive hormone concentrations and ovulation in regularly menstruating women. PMC. 2016.
• Mumford SL, et al. Dietary factors and luteal phase deficiency in healthy eumenorrheic women. PMC. 2016.
• Sharma AK, et al. A prospective, randomized, double-blind, placebo-controlled study on efficacy and safety of Ashwagandha root extract for managing menopausal symptoms. PMC.
• Pouteau E, et al. Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia. PLoS ONE. 2018.
• U.S. Department of Veterans Affairs Whole Health Library. Estrogen Dominance. 2024.
• Rodeheffer C, et al. Effects of Low Vitamin C Intake on Fertility Parameters and Pregnancy Outcomes in Guinea Pigs. PMC. 2023.
• Drummond C, et al. Dietary energy intake across the menstrual cycle: a narrative review. Nutrition Reviews. PMC. 2023.